123 related articles for article (PubMed ID: 25539072)
21. Chan-Yu-Bao-Yuan-Tang induces apoptosis in NSCLC and SCLC cell lines via a mitochondria-mediated pathway.
Zhang Y; Zeng F; Liu X; Li Y; Zhou J; Huang Y; Wang Y; Zhou S; Zhu W; Shu E; Zhou G; Chen G
Xenobiotica; 2011 Jul; 41(7):593-602. PubMed ID: 21446835
[TBL] [Abstract][Full Text] [Related]
22. A synthetic naringenin derivative, 5-hydroxy-7,4'-diacetyloxyflavanone-N-phenyl hydrazone (N101-43), induces apoptosis through up-regulation of Fas/FasL expression and inhibition of PI3K/Akt signaling pathways in non-small-cell lung cancer cells.
Bak Y; Kim H; Kang JW; Lee DH; Kim MS; Park YS; Kim JH; Jung KY; Lim Y; Hong J; Yoon DY
J Agric Food Chem; 2011 Sep; 59(18):10286-97. PubMed ID: 21877710
[TBL] [Abstract][Full Text] [Related]
23. Kctd20 promotes the development of non-small cell lung cancer through activating Fak/AKT pathway and predicts poor overall survival of patients.
Zhang X; Zhou H; Cai L; Fan C; Liu Y; Wang L; Li Q; Miao Y
Mol Carcinog; 2017 Sep; 56(9):2058-2065. PubMed ID: 28398603
[TBL] [Abstract][Full Text] [Related]
24. Effects of artonin e on migration and invasion capabilities of human lung cancer cells.
Plaibua K; Pongrakhananon V; Chunhacha P; Sritularak B; Chanvorachote P
Anticancer Res; 2013 Aug; 33(8):3079-88. PubMed ID: 23898063
[TBL] [Abstract][Full Text] [Related]
25. Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3-dependent invasion in resistant non-small cell lung cancer cells.
Azijli K; Yuvaraj S; Peppelenbosch MP; Würdinger T; Dekker H; Joore J; van Dijk E; Quax WJ; Peters GJ; de Jong S; Kruyt FA
J Cell Sci; 2012 Oct; 125(Pt 19):4651-61. PubMed ID: 22797920
[TBL] [Abstract][Full Text] [Related]
26. Antroquinonol Targets FAK-Signaling Pathway Suppressed Cell Migration, Invasion, and Tumor Growth of C6 Glioma.
Thiyagarajan V; Tsai MJ; Weng CF
PLoS One; 2015; 10(10):e0141285. PubMed ID: 26517117
[TBL] [Abstract][Full Text] [Related]
27. Arecoline Promotes Migration of A549 Lung Cancer Cells through Activating the EGFR/Src/FAK Pathway.
Chang CH; Chen MC; Chiu TH; Li YH; Yu WC; Liao WL; Oner M; Yu CR; Wu CC; Yang TY; Teng CJ; Chiu KY; Chen KC; Wang HY; Yue CH; Lai CH; Hsieh JT; Lin H
Toxins (Basel); 2019 Mar; 11(4):. PubMed ID: 30925742
[TBL] [Abstract][Full Text] [Related]
28. Cinnamomum Cassia Extracts Suppress Human Lung Cancer Cells Invasion by Reducing u-PA/MMP Expression through the FAK to ERK Pathways.
Wu HC; Horng CT; Lee YL; Chen PN; Lin CY; Liao CY; Hsieh YS; Chu SC
Int J Med Sci; 2018; 15(2):115-123. PubMed ID: 29333095
[No Abstract] [Full Text] [Related]
29. Butyrate regulates the expression of c-Src and focal adhesion kinase and inhibits cell invasion of human colon cancer cells.
Lee JC; Maa MC; Yu HS; Wang JH; Yen CK; Wang ST; Chen YJ; Liu Y; Jin YT; Leu TH
Mol Carcinog; 2005 Aug; 43(4):207-14. PubMed ID: 16001424
[TBL] [Abstract][Full Text] [Related]
30. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
Johnson FM; Saigal B; Talpaz M; Donato NJ
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6924-32. PubMed ID: 16203784
[TBL] [Abstract][Full Text] [Related]
31. Role of focal adhesion kinase in regulating YB-1-mediated paclitaxel resistance in ovarian cancer.
Kang Y; Hu W; Ivan C; Dalton HJ; Miyake T; Pecot CV; Zand B; Liu T; Huang J; Jennings NB; Rupaimoole R; Taylor M; Pradeep S; Wu SY; Lu C; Wen Y; Huang J; Liu J; Sood AK
J Natl Cancer Inst; 2013 Oct; 105(19):1485-95. PubMed ID: 24062525
[TBL] [Abstract][Full Text] [Related]
32. Myricetin inhibits advanced glycation end product (AGE)-induced migration of retinal pericytes through phosphorylation of ERK1/2, FAK-1, and paxillin in vitro and in vivo.
Kim YS; Kim J; Kim KM; Jung DH; Choi S; Kim CS; Kim JS
Biochem Pharmacol; 2015 Feb; 93(4):496-505. PubMed ID: 25450667
[TBL] [Abstract][Full Text] [Related]
33. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.
Behmoaram E; Bijian K; Jie S; Xu Y; Darnel A; Bismar TA; Alaoui-Jamali MA
Am J Pathol; 2008 Nov; 173(5):1540-50. PubMed ID: 18832579
[TBL] [Abstract][Full Text] [Related]
34. CX3CL1 promotes lung cancer cell migration and invasion via the Src/focal adhesion kinase signaling pathway.
Liu W; Liang Y; Chan Q; Jiang L; Dong J
Oncol Rep; 2019 Mar; 41(3):1911-1917. PubMed ID: 30628679
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of lung cancer cell proliferation by CD40 signaling through tumor necrosis factor I.
Lu XD; Zhu XL; Chen C; Zhang GB; Zhang XG; Huang JA
Ai Zheng; 2009 Jan; 28(1):20-3. PubMed ID: 19448410
[TBL] [Abstract][Full Text] [Related]
36. Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer.
Homma S; Ishii Y; Morishima Y; Yamadori T; Matsuno Y; Haraguchi N; Kikuchi N; Satoh H; Sakamoto T; Hizawa N; Itoh K; Yamamoto M
Clin Cancer Res; 2009 May; 15(10):3423-32. PubMed ID: 19417020
[TBL] [Abstract][Full Text] [Related]
37. Maclurin suppresses migration and invasion of human non-small-cell lung cancer cells via anti-oxidative activity and inhibition of the Src/FAK-ERK-β-catenin pathway.
Ku MJ; Kim JH; Lee J; Cho JY; Chun T; Lee SY
Mol Cell Biochem; 2015 Apr; 402(1-2):243-52. PubMed ID: 25630491
[TBL] [Abstract][Full Text] [Related]
38. A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth.
Shi Q; Hjelmeland AB; Keir ST; Song L; Wickman S; Jackson D; Ohmori O; Bigner DD; Friedman HS; Rich JN
Mol Carcinog; 2007 Jun; 46(6):488-96. PubMed ID: 17219439
[TBL] [Abstract][Full Text] [Related]
39. Fangchinoline derivatives inhibits PI3K signaling in vitro and in vivo in non-small cell lung cancer.
Chen JS; Guo X; Sun JY; Wang MX; Gao XZ; Wang Z; Han JL; Sun H; Zhang K; Liu C
Bioorg Chem; 2023 Sep; 138():106623. PubMed ID: 37295240
[TBL] [Abstract][Full Text] [Related]
40. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
Li X; Wang X; Ye H; Peng A; Chen L
Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
